BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
DTSTART:20190331T030000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20191027T020000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260405T192632Z
UID:1560344400@ist.ac.at
DTSTART:20190612T150000
DTEND:20190612T160000
DESCRIPTION:Speaker: Ulrich Mühlner\nhosted by Alexander Schwartz\nAbstrac
 t: The future is approaching more rapidly than ever. From transport and en
 ergy to finance and manufacturing\, exponential advances in new technologi
 es like artificial intelligence (AI) are transforming some of the most con
 servative industries worldwide and are changing the ‘rules of the game
 ’ allowing new players to enter and take over these industries. It is a 
 time of great opportunity and great risk for the healthcare industry and t
 heir established players.Currently\, healthcare is largely inefficient and
  not fulfilling the needs of the patients but also the healthcare provider
 s. We are seeing constantly increasing healthcare costs while patient outc
 omes remain insufficient. At the same time\, developing new drugs becomes 
 more and more expensive with fully-loaded total costs exceeding USD 2bn fo
 r a new drug. Hence\, the current economic model is unsustainable given th
 e dramatically increasing costs to bring a new medication to the market wh
 ile the prices for new drugs are under pressure by healthcare systems. At 
 the same time\, we see an explosion of data (from ‘omics’ to patient-g
 enerated health data) which requires a fundamentally new approach to healt
 hcare.Therefore\, there is no doubt that the next big industry poised for 
 radical disruption by new technologies like digital health and artificial 
 intelligence is the healthcare industry.The presentation will provide an o
 verview of the major challenges and trends in healthcare\, highlight speci
 fic innovation examples like novel digital physician / patient communicati
 on platforms and AI in pharmaceutical drug discovery & development based o
 n the presenter’s own experience and active involvement\, and discuss a 
 roadmap to the future of healthcare.About Ulrich MühlnerUlrich Mühlner i
 s a senior healthcare executive with 20 years of industry experience. In 2
 016\, he became an active startup investor and entrepreneur to enable life
 -changing healthcare innovations by joining forces with scientists\, innov
 ators\, and entrepreneurs\, and - together - translating groundbreaking id
 eas\, discoveries\, and inventions into services and products that make a 
 real difference to people’s lives. Dr Mühlner is particularly passionat
 e about transforming the healthcare industry towards personalized and valu
 e-based healthcare through Digital Health solutions\, in particular in the
  areas of Connected Care\, Patient-Generated Health Data (PGHD) / Real Wor
 ld Evidence\, and Artificial Intelligence / Deep Learning. To fulfill this
  mission\, Ulrich Mühlner co-founded docdok.health to develop docdok\, a 
 GDPR and HIPAA compliant cloud based solution connecting healthcare provid
 ers with their patients in the clinical and study ecosystems\, 24/7\, on a
 ll devices enabling to capture objective real world data (RWD) in addition
  to subjective patient reported outcomes (PROs) while significantly benefi
 ting both patients and doctors. He also serves globally as board member an
 d advisor to biopharma and digital health / health tech companies (e.g.\, 
 E-Medicus\, Insilico Medicine\, Medicinisto)\, as well as international or
 ganizations and leading academic institutions. Ulrich Mühlner is a freque
 nt speaker and panelist at international biopharma\, medtech\, and health 
 tech / digital health conferences.Previously\, Dr Mühlner worked at Novar
 tis and Boston Consulting Group (BCG). At Novartis he served as Director a
 nd Head Global Corporate Strategy\, Global Head Digital Health / Healthtec
 h Partnerships. In these roles\, he was responsible for the multi-billion 
 dollar portfolio transformation strategy and spearheaded globally the digi
 tal health activities across Novartis leading to major digital health part
 nerships (Google/Verily\, IBM\, Proteus) with the aim to better serve pati
 ents while increasing the value of the Novartis portfolio through ‘beyon
 d-the-drug’ real-world outcomes solutions. In total\, Dr Mühlner succes
 sfully executed partnership deals with a volume of $350mn. Dr Mühlner stu
 died Biochemistry in Hannover and Munich\, and earned a PhD degree in Bioc
 hemistry and Molecular Biology based on his research on molecular mechanis
 ms of cancer development at the Research Institute of Molecular Pathology 
 (I.M.P.) in Vienna.
LOCATION:Room Down-Town (under the Crazy Duck Pub)\, ISTA
ORGANIZER:thomas.zauner@ist.ac.at
SUMMARY:Ulrich Mühlner: TWIST Talk: The Future of Healthcare
URL:https://talks-calendar.ista.ac.at/events/2005
END:VEVENT
END:VCALENDAR